Response by Wang Et Al to Letter Regarding Article, "magnitude of Soluble ST2 As a Novel Biomarker for Acute Aortic Dissection".
Yuan Wang,Pei Gao,Jie Du
DOI: https://doi.org/10.1161/circulationaha.118.036720
IF: 37.8
2018-01-01
Circulation
Abstract:HomeCirculationVol. 138, No. 12Response by Wang et al to Letter Regarding Article, “Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection” Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBResponse by Wang et al to Letter Regarding Article, “Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection” Yuan Wang, MD, PhD, Pei Gao, PhD and Jie Du, PhD Yuan WangYuan Wang Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Centre for Cardiovascular Disorders, China (Y.W., J.D.). Beijing Institute of Heart, Lung, and Blood Vessel Disease, China (Y.W., J.D.). Search for more papers by this author , Pei GaoPei Gao Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China (P.G.). *Drs Gao and Du contributed equally. Search for more papers by this author and Jie DuJie Du Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Centre for Cardiovascular Disorders, China (Y.W., J.D.). Beijing Institute of Heart, Lung, and Blood Vessel Disease, China (Y.W., J.D.). *Drs Gao and Du contributed equally. Search for more papers by this author Originally published17 Sep 2018https://doi.org/10.1161/CIRCULATIONAHA.118.036720Circulation. 2018;138:1281–1282In Response:We appreciate the letter submitted by Dr Zhang and colleagues regarding our recently published article, which demonstrated that soluble ST2 (sST2) could be a useful biomarker for aortic dissection (AD) to discriminate acute AD from other diseases presenting with acute chest pain.1 In the same issue of Circulation, Nazerian and colleagues evaluated the diagnostic performance of the rule-out strategy using the aortic dissection detection risk score (ADD-RS) plus D-dimer under similar circumstances.2 Dr Zhang and colleagues then raised an interesting point of whether combining AAD-RS with sST2 for early diagnosis of acute AD may provide additional value. We agree that integration of pretest probability assessment with sST2 is feasible. According to the clinical guideline,3 the generally used tool for pretest probability assessment was ADD-RS, by which patients can be generally classified into 3 categories. Therefore, we now evaluated the similar rule-out strategy using sST2 in addition to AAD-RS in the validation set in our study. Overall, 186 patients had relative information on individual risk factors for AAD-RS. The area under the receiver operating characteristic curve for these patients using sST2 alone or AAD-RS plus sST2 was very similar (ie, 0.94 [0.91, 0.97] for sST2 alone and 0.95 [0.92, 0.98] for AAD-RS plus sST2, respectively). The area under the receiver operating characteristic curve for AAD-RS plus D-dimer was lower in these patients (ie, 0.87 [0.82, 0.92]), which is consistent with the finding in our original article. Moreover, combining ADD-RS≤1 plus D-dimer<500 ng/mL as the rule-out diagnostic strategy in these patients had sensitivity of 90%, specificity of 73%, accuracy of 80%, positive predictive value of 52%, negative predictive value of 96%, positive likelihood ratio of 3.3, and negative likelihood ratio of 0.13. In comparison, combining ADD-RS≤1 plus sST2<35 ng/mL as the rule-out diagnostic strategy in these patients had sensitivity of 99%, specificity of 72%, accuracy of 82%, positive predictive value of 54%, negative predictive value of 99%, positive likelihood ratio of 3.5, and negative likelihood ratio of 0.02. This finding demonstrates that combining AAD-RS with sST2 could be a more promising strategy for the diagnosis of acute AD. However, confirmation from future studies is required.Secondly, in the validation study, we found that sST2 levels were broadly similar in patients with or without extensive myocardial infarction (P=0.17). However, in patients with pulmonary embolism, we only found that 4 of 24 patients had the condition of massive pulmonary embolism. It is difficult to judge whether massive pulmonary embolism had certain effect on levels of sST2 given the limited number of patients available.We thank again Zhang and Xu for their interest and raising the possibility to extend the use of sST2 in addition to the existing pretest probability assessment. In conclusion, we believe that integration of ADD-RS with sST2 may be considered as a rule-out diagnostic strategy for early diagnosis of acute AD. However, future large prospective multicenter studies are required to demonstrate the diagnostic efficacy and accuracy of this strategy.DisclosuresNone.Footnotes*Drs Gao and Du contributed equally.https://www.ahajournals.org/journal/circReferences1. Wang Y, Tan X, Gao H, Yuan H, Hu R, Jia L, Zhu J, Sun L, Zhang H, Huang L, Zhao D, Gao P, Du J. Magnitude of soluble ST2 as a novel biomarker for acute aortic dissection.Circulation. 2018; 137:259–269. doi: 10.1161/CIRCULATIONAHA.117.030469LinkGoogle Scholar2. Nazerian P, Mueller C, Soeiro AM, Leidel BA, Salvadeo SAT, Giachino F, Vanni S, Grimm K, Oliveira MT, Pivetta E, Lupia E, Grifoni S, Morello F; ADvISED Investigators. Diagnostic accuracy of the aortic dissection detection risk score plus D-dimer for acute aortic syndromes: the ADvISED Prospective Multicenter Study.Circulation. 2018; 137:250–258. doi: 10.1161/CIRCULATIONAHA.117.029457LinkGoogle Scholar3. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).Eur Heart J. 2014; 35:2873–2926. doi: 10.1093/eurheartj/ehu281CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails September 18, 2018Vol 138, Issue 12 Advertisement Article InformationMetrics © 2018 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.118.036720PMID: 30354437 Originally publishedSeptember 17, 2018 PDF download Advertisement SubjectsAortic Dissection